{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:40:49Z","timestamp":1781188849767,"version":"3.54.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,7]]},"abstract":"<jats:p>Primary aldosteronism (PA) is a frequent cause of secondary hypertension. Studies on the prevalence of PA are lacking in the Middle East region. To determine the proportion of patients with high aldosterone-to-renin ratio (ARR) among Lebanese patients with hypertension screened for PA and to compare their clinical and biological characteristics with patients with essential hypertension. A retrospective review of medical charts of patients with hypertension undergoing sampling of serum aldosterone and plasma renin concentration at a tertiary care center between October 2022 and 2023 was conducted. Of 144 patients with hypertension screened for PA, 23 (16%) had an ARR higher than 3.7\u2009ng\/dL\/mU\/L and serum aldosterone above 15\u2009ng\/dL. The mean age of the screened population was 51\u2005\u00b1\u200515 years, 56% were men. The median duration of hypertension was 4 years and the median number was 2 of antihypertensive medications. Patients with a positive screening test were mostly men (88%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.0001), and more frequently had diabetes (50%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.0001) than those with essential hypertension. Only 22% had hypokalemia. Of the 23 patients, 11 underwent intravenous saline suppression testing; PA was confirmed in all of them. The high frequency of PA in our center is comparable to other countries. More studies are needed to determine how to reduce healthcare disparities and overcome the barriers to appropriate diagnosis and treatment.<\/jats:p>","DOI":"10.1097\/md.0000000000041384","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T20:00:07Z","timestamp":1739217607000},"page":"e41384","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["High prevalence of primary aldosteronism in a tertiary care hospital in Lebanon"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6205-8206","authenticated-orcid":false,"given":"Isabelle","family":"Jambart","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Ho\u0302tel-Dieu de France Hospital, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Kassab","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Ho\u0302tel-Dieu de France Hospital, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Gannag\u00e9-Yared","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Ho\u0302tel-Dieu de France Hospital, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kassab","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ho\u0302tel-Dieu de France Hospital, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charbel","family":"Naim","sequence":"additional","affiliation":[{"name":"Department of Cardiology at Lebanese American University Medical Center, Rizk Hospital, Beirut, Lebanon."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"El Ghorayeb","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Ho\u0302tel-Dieu de France Hospital, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250210","first-page":"1889","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline.","volume":"101","author":"Funder","year":"2015","journal-title":"J Clin Hypertens"},{"key":"R2-20250210","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.7326\/0003-4819-66-6-1079","article-title":"Hypokalemia in the hypertensive patient.","volume":"66","author":"Kaplan","year":"1967","journal-title":"Ann Intern Med"},{"key":"R3-20250210","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1097\/00004872-199312050-00134","article-title":"How common is primary aldosteronism? Is it the most frequent cause of curable hypertension?","volume":"11","author":"Gordon","year":"1993","journal-title":"J Hypertens"},{"key":"R4-20250210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-022-03084-x","article-title":"Performance of the aldosterone-to-renin ratio as a screening test for primary aldosteronism in primary care.","volume":"77","author":"Ariens","year":"2022","journal-title":"Endocrine"},{"key":"R5-20250210","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis.","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20250210","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension.","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"R7-20250210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MNH.0000000000000702","article-title":"How common is primary aldosteronism?","volume":"30","author":"Hundemer","year":"2021","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R8-20250210","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.3399\/bjgp18X694589","article-title":"Prevalence of primary aldosteronism in primary care: a cross-sectional study.","volume":"68","author":"K\u00e4yser","year":"2018","journal-title":"Br J Gen Pract"},{"key":"R9-20250210","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/ajh\/hpac079","article-title":"Primary aldosteronism: state-of-the-art review.","volume":"35","author":"Vaidya","year":"2022","journal-title":"Am J Hypertens"},{"key":"R10-20250210","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.34067\/KID.0000922020","article-title":"Hyperaldosteronism: how current concepts are transforming the diagnostic and therapeutic paradigm.","volume":"1","author":"Lattanzio","year":"2020","journal-title":"Kidney360"},{"key":"R11-20250210","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1157\/13117734","article-title":"Prevalence of primary aldosteronism in hypertensive patients and its effect on the heart.","volume":"61","author":"Morillas","year":"2008","journal-title":"Rev Esp Cardiol"},{"key":"R12-20250210","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/endrev\/bnad026","article-title":"Treating primary aldosteronism-induced hypertension: novel approaches and future outlooks.","volume":"45","author":"Mullen","year":"2024","journal-title":"Endocr Rev"},{"key":"R13-20250210","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ecl.2019.08.002","article-title":"Primary aldosteronism diagnosis and management: a clinical approach.","volume":"48","author":"Hundemer","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R14-20250210","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/jch.12485","article-title":"Prevalence, awareness, treatment, and control of hypertension in lebanon.","volume":"17","author":"Matar","year":"2015","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R15-20250210","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tem.2005.02.010","article-title":"Aldosterone as a cardiovascular risk factor.","volume":"16","author":"Rossi","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"R16-20250210","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1097\/HJH.0000000000003822","article-title":"Primary aldosteronism prevalence enhanced by strict adherence to 2016 Endocrine Society guidelines: insights from an endocrine hypertension unit.","volume":"42","author":"Ruiz-Sanchez","year":"2024","journal-title":"J Hypertens"},{"key":"R17-20250210","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eprac.2020.10.007","article-title":"Prevalence, subtype classification, and outcomes of treatment of primary aldosteronism: a prospective study in China.","volume":"27","author":"Xu","year":"2021","journal-title":"Endocr Pract"},{"key":"R18-20250210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1590\/S0066-782X2009000100007","article-title":"Prevalence of primary hyperaldosteronism in a systemic arterial hypertension league.","volume":"92","author":"Ribeiro","year":"2009","journal-title":"Arq Bras Cardiol"},{"key":"R19-20250210","first-page":"2854","article-title":"Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore.","volume":"85","author":"Loh","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-20250210","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1055\/a-1938-4242","article-title":"Prevalence of primary aldosteronism in newly diagnosed hypertensive patients in primary care.","volume":"130","author":"Asbach","year":"2022","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R21-20250210","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41371-020-00458-4","article-title":"China nationwide screening and registry of primary aldosteronism in hypertensive patients.","volume":"35","author":"Chen","year":"2021","journal-title":"J Hum Hypertens"},{"key":"R22-20250210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","article-title":"Primary aldosteronism and hypertensive disease.","volume":"42","author":"Mosso","year":"2003","journal-title":"Hypertension"},{"key":"R23-20250210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1291\/hypres.27.193","article-title":"Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.","volume":"27","author":"Omura","year":"2004","journal-title":"Hypertens Res"},{"key":"R24-20250210","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice.","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R25-20250210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/sj.jhh.1001554","article-title":"Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region.","volume":"17","author":"Strauch","year":"2003","journal-title":"J Hum Hypertens"},{"key":"R26-20250210","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0895-7061(02)02969-2","article-title":"High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives.","volume":"15","author":"Rossi","year":"2002","journal-title":"Am J Hypertens"},{"key":"R27-20250210","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","article-title":"Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers.","volume":"20","author":"Gordon","year":"1993","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R28-20250210","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/cen.14409","article-title":"High prevalence and a long delay in the diagnosis of primary aldosteronism among patients with young-onset hypertension.","volume":"94","author":"Alam","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R29-20250210","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2015-3915","article-title":"Basal and post-ACTH aldosterone and its ratios are useful during adrenal vein sampling in primary aldosteronism.","volume":"101","author":"El Ghorayeb","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-20250210","doi-asserted-by":"crossref","first-page":"712","DOI":"10.31128\/AJGP-05-18-4587","article-title":"Current pattern of primary aldosteronism diagnosis: delayed and complicated.","volume":"47","author":"Lim","year":"2018","journal-title":"Aust J Gen Pract"},{"key":"R32-20250210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0337-9","article-title":"Genetic causes of primary aldosteronism.","volume":"51","author":"Seidel","year":"2019","journal-title":"Exp Mol Med"},{"key":"R33-20250210","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/HYPERTENSIONAHA.123.21965","article-title":"Diagnostic delay and disease burden in primary aldosteronism: an international patient survey.","volume":"81","author":"Ananda","year":"2024","journal-title":"Hypertension"},{"key":"R34-20250210","first-page":"59","article-title":"Potassium disorders: hypokalemia and hyperkalemia.","volume":"107","author":"Kim","year":"2023","journal-title":"Am Fam Physician"},{"key":"R35-20250210","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R36-20250210","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/a-1134-4980","article-title":"Hypokalemia and the prevalence of primary aldosteronism.","volume":"52","author":"Gruber","year":"2020","journal-title":"Horm Metab Res"},{"key":"R37-20250210","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit.","volume":"75","author":"Burrello","year":"2020","journal-title":"Hypertension"},{"key":"R38-20250210","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM196511182732106","article-title":"Hypertension, the potassium ion and impaired carbohydrate tolerance.","volume":"273","author":"Conn","year":"1965","journal-title":"N Engl J Med"},{"key":"R39-20250210","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/HYPERTENSIONAHA.119.13922","article-title":"Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans.","volume":"75","author":"Adler","year":"2020","journal-title":"Hypertension"},{"key":"R40-20250210","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/dc18-1293","article-title":"High prevalence of diabetes in patients with primary aldosteronism (PA) associated with subclinical hypercortisolism and prediabetes more prevalent in bilateral than unilateral PA: a large, multicenter cohort study in Japan.","volume":"42","author":"Akehi","year":"2019","journal-title":"Diabetes Care"},{"key":"R41-20250210","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/cen.14598","article-title":"Prevalence of primary aldosteronism in type 2 diabetes mellitus and hypertension: a prospective study from Western India.","volume":"96","author":"Memon","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R42-20250210","doi-asserted-by":"crossref","first-page":"dgz293","DOI":"10.1210\/clinem\/dgz293","article-title":"Determining the prevalence of primary aldosteronism in patients with new-onset type 2 diabetes and hypertension.","volume":"105","author":"Hu","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R43-20250210","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3390\/biomedicines10092308","article-title":"High prevalence of primary aldosteronism in patients with type 2 diabetes mellitus and hypertension.","volume":"10","author":"Tyfoxylou","year":"2022","journal-title":"Biomedicines"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T20:00:20Z","timestamp":1739217620000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041384","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}